Title:
NOVEL COMPOUND USEFUL FOR EGFR INHIBITION AND TUMOR TREATMENT
Document Type and Number:
Japanese Patent JP2020023441
Kind Code:
A
Abstract:
To develop a covalent drug which is less in concern of side effect and safe by searching a reaction group having milder reactivity and changing to a Michael acceptor, and designing an agent molecule by using the same.SOLUTION: The invention relates to for example a compound represented by the following formula (I), a pharmaceutically acceptable salt thereof, or the like.SELECTED DRAWING: None
Inventors:
OJIDA AKIO
ONO MAYUMI
WATARI KOSUKE
SHINDO NAOYA
FUCHIDA YAMATO
ONO MAYUMI
WATARI KOSUKE
SHINDO NAOYA
FUCHIDA YAMATO
Application Number:
JP2016215520A
Publication Date:
February 13, 2020
Filing Date:
November 02, 2016
Export Citation:
Assignee:
UNIV KYUSHU
International Classes:
C07D239/94; A61K31/517; A61K31/5377; A61P11/00; A61P35/00; A61P35/02; A61P43/00; C07D401/12; C07D403/12; C07D405/12; C07D409/12
Attorney, Agent or Firm:
Hiroshi Kobayashi
Norio Omori
Koichi Iwata
Yasuhito Suzuki
Norio Omori
Koichi Iwata
Yasuhito Suzuki